PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Небольшая подборка полезной литературы

Опубликовано 6 марта, 201930 июня, 2019 frozencat

Data And Safety Monitoring Committees In Clinical Trials

Epidemiology and Biostatistics An Introduction to Clinical Research

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trials Using R

Clinical trial data analysis with R and SAS

Clinical Trials Design in Operative and Non Operative Invasive Procedures

Analyzing Longitudinal Clinical Trial Data: A Practical Guide

Bioequivalence and Statistics in Clinical Pharmacology, Second Edition

Design and Analysis of Bioavailability and Bioequivalence Studies

Biomaterials in Clinical Practice : Advances in Clinical Research and Medical Devices

Fundamental Statistical Inference A Computational Approach

Statistics and Simulation

Medical biostatistics

Biostatistics

Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development

Biosimilar Clinical Development: Scientific Considerations and New Methodologies

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Расчет доверительных интервалов для 2X2 биоэквивалентности: Julia concept code
Следующая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20170731 132822
20180202 170847
IMG-20170807-WA0038
20170729 214001
20180131 140112
20180814 153419
  • Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 18, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-14
  • List of Drug Master Files (DMFs)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-14 By FDA
  • FDA Listing of Authorized Generics
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-14 By FDA
  • Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 34, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-13
  • Human medicines European public assessment report (EPAR): Oxlumo, lumasiran, Date of authorisation: 19/11/2020, Revision: 6, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-13
  • Human medicines European public assessment report (EPAR): Mycamine, micafungin, Date of authorisation: 25/04/2008, Revision: 22, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-13
  • Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-13
  • FDA Approves Labeling Changes that Include a Boxed Warning for Immune Effector Cell-associated Enterocolitis Following Treatment with Ciltacabtagene Autoleucel (CARVYKTI, Janssen Biotech, Inc.)
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-10-11 By FDA
  • ICH M13B Webinar: Navigating the Draft ICH M13B Additional Strengths Biowaiver Guideline - 09/11/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-10 By FDA
  • GDUFA III Reauthorization
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-10 By FDA
  • CARVYKTI
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-10-10 By FDA
  • GDUFA IV: Fiscal Years 2028 – 2032
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-10 By FDA
  • Generic Drugs - Specific Labeling Resources
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-10-10 By FDA
  • Human medicines European public assessment report (EPAR): Syfovre, pegcetacoplan, Date of refusal: 16/12/2024, Status: Refused
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-10-10
  • ADSTILADRIN
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-10-10 By FDA
Предыдущие записи
Тема: Scaffold от Danny Cooper.